Abu Dhabi Investment Authority (ADIA) takes a lower stake in hologic inc. Marlborough, a Massachusetts-based company is a global leader in women’s health, dedicated to managing health conditions and raising the standard of care around the world.
ADIA is part of a consortium that takes over a private company. It includes funds owned by Blackstone and TPG. The transaction is valued at US$79 per share, representing an enterprise value of US$18.3 billion.
The transaction is expected to close in the first half of calendar year 2026, subject to the approval of Hology’s system owners, other regulatory approvals and the satisfaction of certain customary closing conditions. It was expressly approved by the Hologic Board of Directors, which recommended that Stockholders vote their shares to approve the transaction and adopt the merger agreement.
Hologic has delivered full-year revenue of US$4.03 billion by 2024, and has issued guidance to increase it to US$4.15 billion from US$4.2 billion by FY202 billion for FY202. After the announcement of the transaction, the company plans to report its financial results for the fourth quarter of FISCAL 2025 on November 3. However, it does not intend to provide financial guidance for fiscal 2026 in the announcement.
Holologic to Go Privately Post-Deal
Blackstone and TPG will acquire all the outstanding shoological shares for US $ 76 in cash at a price against this Internet, CVR) to get up to US $ 3 for two shares at US $ 1.50 each. The non-tradable CVR will be issued to hologic stockholders at closing and paid to meet certain global profit targets for the hologic life business in 2026 and 2027.
The combined purchase price represents a 46 percent premium to hologic’s closing price on May 23, 2025, the last full trading day before press releases regarding the company.
Upon completion of the transaction, Hologic common stock will be listed on the Nasdaq stock market. The company will retain its headquarters in Marlborough, and will continue to operate under the hologic name and brand.
Stephen P Macmillan, Hologic’s chairman, CEO, said: “Today marks an exciting new chapter for Hologic as we leverage the power of Blackstone and TPG. Our resources.
“This transaction delivers immediate and compelling value to spoolds
Ram Jagannath, Chief Managing Director at Blackstone, added: “Hologic is a prominent global leader in advancing women’s health, with a killer reputation for high-quality medical device and diagnostic products.
“We have followed this company closely for many years and have long loved the positive impact its life-changing technology has had on millions of patients around the world.”
